This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1dx5
From Proteopedia
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
| - | The serine proteinase alpha-thrombin causes blood clotting through, proteolytic cleavage of fibrinogen and protease-activated receptors and, amplifies its own generation by activating the essential clotting factors, V and VIII. Thrombomodulin, a transmembrane thrombin receptor with six, contiguous epidermal growth factor-like domains (TME1-6), profoundly, alters the substrate specificity of thrombin from pro- to anticoagulant by, activating protein C. Activated protein C then deactivates the coagulation, cascade by degrading activated factors V and VIII. The, thrombin-thrombomodulin complex inhibits fibrinolysis by activating the, procarboxypeptidase thrombin-activatable fibrinolysis inhibitor. Here we, present the 2.3 A crystal structure of human alpha-thrombin bound to the, smallest ... | + | The serine proteinase alpha-thrombin causes blood clotting through, proteolytic cleavage of fibrinogen and protease-activated receptors and, amplifies its own generation by activating the essential clotting factors, V and VIII. Thrombomodulin, a transmembrane thrombin receptor with six, contiguous epidermal growth factor-like domains (TME1-6), profoundly, alters the substrate specificity of thrombin from pro- to anticoagulant by, activating protein C. Activated protein C then deactivates the coagulation, cascade by degrading activated factors V and VIII. The, thrombin-thrombomodulin complex inhibits fibrinolysis by activating the, procarboxypeptidase thrombin-activatable fibrinolysis inhibitor. Here we, present the 2.3 A crystal structure of human alpha-thrombin bound to the, smallest thrombomodulin fragment required for full protein-C co-factor, activity, TME456. The Y-shaped thrombomodulin fragment binds to thrombin's, anion-binding exosite-I, preventing binding of procoagulant substrates., Thrombomodulin binding does not seem to induce marked allosteric, structural rearrangements at the thrombin active site. Rather, docking of, a protein C model to thrombin-TME456 indicates that TME45 may bind, substrates in such a manner that their zymogen-activation cleavage sites, are presented optimally to the unaltered thrombin active site. |
==About this Structure== | ==About this Structure== | ||
| - | 1DX5 is a | + | 1DX5 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with NDG, CA, NA and FMT as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Thrombin Thrombin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.5 3.4.21.5] Structure known Active Sites: AC1, AC2, AC3 and AC4. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1DX5 OCA]. |
==Reference== | ==Reference== | ||
| Line 33: | Line 33: | ||
[[Category: serine proteinase]] | [[Category: serine proteinase]] | ||
| - | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 5 14:02:40 2007'' |
Revision as of 11:57, 5 November 2007
|
CRYSTAL STRUCTURE OF THE THROMBIN-THROMBOMODULIN COMPLEX
Overview
The serine proteinase alpha-thrombin causes blood clotting through, proteolytic cleavage of fibrinogen and protease-activated receptors and, amplifies its own generation by activating the essential clotting factors, V and VIII. Thrombomodulin, a transmembrane thrombin receptor with six, contiguous epidermal growth factor-like domains (TME1-6), profoundly, alters the substrate specificity of thrombin from pro- to anticoagulant by, activating protein C. Activated protein C then deactivates the coagulation, cascade by degrading activated factors V and VIII. The, thrombin-thrombomodulin complex inhibits fibrinolysis by activating the, procarboxypeptidase thrombin-activatable fibrinolysis inhibitor. Here we, present the 2.3 A crystal structure of human alpha-thrombin bound to the, smallest thrombomodulin fragment required for full protein-C co-factor, activity, TME456. The Y-shaped thrombomodulin fragment binds to thrombin's, anion-binding exosite-I, preventing binding of procoagulant substrates., Thrombomodulin binding does not seem to induce marked allosteric, structural rearrangements at the thrombin active site. Rather, docking of, a protein C model to thrombin-TME456 indicates that TME45 may bind, substrates in such a manner that their zymogen-activation cleavage sites, are presented optimally to the unaltered thrombin active site.
About this Structure
1DX5 is a Protein complex structure of sequences from Homo sapiens with NDG, CA, NA and FMT as ligands. Active as Thrombin, with EC number 3.4.21.5 Structure known Active Sites: AC1, AC2, AC3 and AC4. Full crystallographic information is available from OCA.
Reference
Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex., Fuentes-Prior P, Iwanaga Y, Huber R, Pagila R, Rumennik G, Seto M, Morser J, Light DR, Bode W, Nature. 2000 Mar 30;404(6777):518-25. PMID:10761923
Page seeded by OCA on Mon Nov 5 14:02:40 2007
Categories: Homo sapiens | Protein complex | Thrombin | Bode, W. | Fuentes-Prior, P. | Huber, R. | Iwanaga, Y. | Light, D.R. | Morser, J. | Pagila, R. | Rumennik, G. | Seto, M. | CA | FMT | NA | NDG | Anticoagulant complex | Antifibrinolytic complex | Egf-like domains | Serine proteinase
